HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ibrahim Ethem Torun Selected Research

Tandem Pore Domain Potassium Channels (Tandem Pore Domain Potassium Channel)

1/2022Activation of TRESK background potassium channels by cloxyquin exerts protective effects against excitotoxic-induced brain injury and neuroinflammation in neonatal rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ibrahim Ethem Torun Research Topics

Disease

3Seizures (Absence Seizure)
01/2022 - 12/2021
3Myoclonus (Nocturnal Myoclonus)
01/2022 - 12/2021
2Pain (Aches)
06/2022 - 01/2022
2Inflammation (Inflammations)
06/2022 - 12/2021
2Neuroinflammatory Diseases
01/2022 - 01/2022
1Hypersensitivity (Allergy)
06/2022
1Edema (Dropsy)
06/2022
1Fever (Fevers)
06/2022
1Brain Injuries (Brain Injury)
01/2022
1Migraine Disorders (Migraine)
01/2022
1Neurogenic Inflammation
01/2022

Drug/Important Bio-Agent (IBA)

3Pentylenetetrazole (Metrazol)IBA
01/2022 - 12/2021
2Anticonvulsants (Antiepileptic Drugs)IBA
01/2022 - 12/2021
2Serotonin (5 Hydroxytryptamine)IBA
01/2022 - 01/2022
2CytokinesIBA
01/2022 - 01/2022
1CarrageenanIBA
06/2022
1Tramadol (K315)FDA LinkGeneric
06/2022
1Glucagon-Like Peptide-1 ReceptorIBA
06/2022
1LiraglutideFDA Link
06/2022
1Glucagon-Like Peptide 1 (GLP 1)IBA
06/2022
1EndocannabinoidsIBA
01/2022
1methanandamideIBA
01/2022
1SR 144528IBA
01/2022
1cloxyquinIBA
01/2022
1RimonabantIBA
01/2022
1p-Methoxy-N-methylphenethylamineIBA
01/2022
1Fluoxetine (Prozac)FDA LinkGeneric
01/2022
1Nitroglycerin (Dynamite)FDA LinkGeneric
01/2022
1LigandsIBA
01/2022
1Substance PIBA
01/2022
1Calcitonin Gene-Related PeptideIBA
01/2022
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2022
1Cannabinoid Receptor AgonistsIBA
01/2022
1capsazepineIBA
01/2022
1Sumatriptan (Imigran)FDA LinkGeneric
01/2022
1Tandem Pore Domain Potassium Channels (Tandem Pore Domain Potassium Channel)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
12/2021
1Oxidants (Oxidizing Agents)IBA
12/2021
1AntioxidantsIBA
12/2021